In particular, for PD-L1 staining, which is regarded as a potential predictive marker for immunotherapy, four of seven pairs (57.1%) were identical in tumor proportion score (TPS) and combined positive score (CPS), and two of seven (28.6%) were nearly identical (0 vs. <1%). This evidence concerns the gene CD274 and neoplasm.